Published on 14th October 2026

How FVG Is Rebuilding Profitability: Cost Discipline, Operational Investment, and the Growth Case for the Long Term

The EMS industry does not reward complacency. Operating margins across the sector sit between 3% and 8% EBITDA, and Asia-Pacific gross margins compressed further into the 4–7% range in 2025 as OEM customers imposed annual price-down clauses that outpaced productivity gains. In that environment, a period of mixed financial momentum is not unusual. What matters is whether a manufacturer is responding with structural changes or simply waiting for conditions to improve.

At Flexi Versa Group (FVG), the response has been structural. Over the past 18 months, the company has been executing a two-track programme: tightening cost discipline across its manufacturing operations in Malaysia while simultaneously investing in the capabilities and market segments that carry the strongest long-term margin potential. Neither track operates in isolation. The cost work funds the investment capacity; the investment work is what converts operational efficiency into durable revenue growth.

The core argument: FVG's current financial position reflects the cost of building a more capable business, not a failure to manage the one it already has. The initiatives described below are the evidence for that position.

Understanding the Margin Environment FVG Operates In

Before evaluating FVG's financial trajectory, it is worth understanding the structural conditions that define profitability in contract electronics manufacturing. This context is not an excuse; it is the baseline against which any improvement programme must be measured.

Why EMS margins are thin by design

Material costs account for 70–85% of total cost of goods sold in EMS operations. That single fact explains most of the margin pressure in the industry. When semiconductor prices swing by double-digit percentages in a quarter, as they did repeatedly during 2024, and customer contracts lock BOM prices months in advance, the gap between contract price and actual input cost falls directly to the manufacturer's bottom line.

For Malaysia-based EMS providers, the environment became measurably harder in mid-2025. Malaysia's industrial electricity tariff rose 14.2% to 45.62 sen per kWh under Regulatory Period 4, the first increase since 2014. The Federation of Malaysian Manufacturers noted that electricity can account for up to 40% of production cost in high-throughput assembly environments. An Automatic Fuel Cost Adjustment mechanism then introduced further variability, with the projected rate for August 2026 sitting at +3.93 sen per kWh above the base tariff.

What the industry data says about the path forward

The same research that documents margin compression also identifies the response. Across the Asia-Pacific EMS sector, analysts project 100–150 basis points of margin expansion through 2026 for companies that accelerate automation investment and supply chain reconfiguration. Manufacturers with facilities in Malaysia and Vietnam are specifically identified as positioned to outperform, given the ongoing migration of 30–40% of China-destined EMS production to friendlier-shore locations.

The implication is clear: the companies that invest through the margin compression cycle, rather than cutting their way through it, are the ones that emerge with a structurally better cost position. That is the logic behind FVG's current programme.

Cost-Reduction Initiatives: Where FVG Is Cutting Without Cutting Corners

Cost reduction in a high-mix, low-volume EMS environment is not straightforward. The product mix at FVG spans precision injection-moulded components, SMT assembly, and full box-build integration across medical devices, semiconductor equipment, and industrial automation. Each product family carries different cost drivers, different quality requirements, and different customer expectations. A blanket cost-cutting approach would damage the very capabilities that differentiate FVG in these demanding verticals.

The approach instead targets four specific areas where savings are achievable without compromising engineering quality or delivery reliability.

1. Material cost and BOM discipline

In EMS, procurement is where the largest financial leverage sits. A 2–6% reduction in material spend translates to approximately 1.5–4% improvement in total manufacturing cost, which at FVG's operating scale represents a meaningful contribution to margin recovery.

FVG has been implementing structured Bill of Materials management practices that reduce the cost of component acquisition without introducing supply risk. The specific levers include:

• Supplier rationalisation: Consolidating the approved vendor list to achieve better pricing leverage with preferred suppliers while reducing qualification overhead

• Alternate component qualification: Pre-qualifying second-source components for high-risk parts, which reduces exposure to spot-market pricing during shortages

• Long-term supply agreements: Locking in pricing on high-volume, stable-demand components to reduce BOM volatility

• Design-to-Cost collaboration: Working with customers during NPI to identify lower-cost component alternatives that meet functional requirements without compromising performance

The last point is particularly important. Design for Manufacturing (DFM) and Design for Assembly (DFA) reviews conducted early in the product development cycle can reduce product manufacturing cost by 3–8% by eliminating unnecessary assembly steps, standardising component selection, and optimising PCB panel layouts. FVG's engineering team embeds these reviews into the NPI process as standard practice, not as an optional add-on.

2. Energy cost mitigation through solar infrastructure

The 14.2% increase in Malaysia's industrial electricity tariff is a direct threat to EMS profitability. SMT reflow ovens, wave solder lines, and automated optical inspection systems are among the most electricity-intensive assets on a manufacturing floor. For FVG, this is not a new problem; it is one the company anticipated by investing in solar-powered operations as a core element of its sustainability strategy.

FVG's solar infrastructure offsets a meaningful portion of grid electricity consumption during peak production hours, when tariff exposure is highest. The financial benefit is twofold: it reduces the absolute cost of energy, and it provides a degree of insulation from the tariff volatility introduced by the Automatic Fuel Cost Adjustment mechanism. As Malaysia's producer price index for electricity and gas rose 9.6% year on year in March 2026, FVG's solar capacity has become a genuine competitive cost advantage rather than a sustainability credential.

3. Lean manufacturing and OEE improvement

Overall Equipment Effectiveness (OEE) measures the proportion of scheduled production time that is genuinely productive. Improving OEE allows a factory to produce more units without adding equipment or headcount, which directly lowers the cost per unit.

FVG has been applying structured lean manufacturing disciplines across its production lines, including:

• Value Stream Mapping to identify and eliminate non-value-added activities

• Predictive and preventive maintenance programmes to reduce unplanned downtime

• SMED (Single Minute Exchange of Die) techniques to reduce changeover time between product runs

• Cellular manufacturing layouts that reduce material movement and waiting time

In a high-mix environment, changeover efficiency is particularly valuable. Faster, more reliable changeovers mean FVG can serve more customers on the same production assets without the scheduling losses that erode margin on short-run programmes.

4. Value Analysis and Value Engineering (VAVE)

For products already in production, Value Analysis and Value Engineering (VAVE) provides a structured methodology for identifying cost reduction opportunities without changing product performance or customer-facing specifications. FVG applies VAVE reviews to mature programmes where the initial NPI cost structure has not been revisited since launch, often surfacing savings through component standardisation, process simplification, or packaging redesign.

Key point: VAVE is not about reducing quality. It is about removing cost that does not contribute to product performance. In regulated industries such as medical devices, VAVE changes are subject to the same engineering change control and qualification requirements as any other design modification.

Long-Term Growth Investments: Where FVG Is Allocating Capital and Why

Cost reduction improves the denominator. Revenue growth and margin mix improvement change the numerator. FVG's investment programme is focused on three areas where the structural demand outlook is strong and where FVG's existing capabilities create a credible competitive position.

Medical device manufacturing

The medical device segment is the most strategically significant growth area in FVG's portfolio. It is also the most demanding. Manufacturers serving this sector must maintain compliance with ISO 13485 quality management systems, demonstrate traceability at the component level, and support regulatory submissions across multiple jurisdictions. These requirements create meaningful barriers to entry that protect margins for qualified suppliers.

FVG has announced a series of strategic initiatives to strengthen its medical device manufacturing capabilities, including infrastructure investment, quality system development, and engineering team expansion. The investment rationale is straightforward: OEMs in the medical sector are accelerating outsourcing as manufacturing complexity increases. Industry analysts project EMS penetration in medical and industrial automation verticals to increase by 7–10% as OEMs recognise specialised manufacturing expertise as a competitive advantage rather than a cost centre.

The margin profile in medical EMS is also materially better than in commodity electronics assembly. Customers in this segment do not make sourcing decisions on price alone; they make them on quality system maturity, engineering depth, and supply chain reliability. FVG's vertically integrated model, which spans injection moulding through to full box-build, is well suited to the integrated manufacturing requirements of medical device OEMs.

Industrial automation and semiconductor equipment

The global EMS market is forecast to reach USD 903 billion by 2031, with industrial automation and AI infrastructure among the fastest-growing end markets. FVG's existing customer base in semiconductor equipment and industrial automation positions the company to benefit from this expansion without requiring a significant pivot in capabilities.

The key investment here is in engineering depth rather than production capacity. Customers building complex industrial systems require a manufacturing partner that can engage at the design stage, support NPI through engineering change cycles, and maintain quality systems that meet the reliability requirements of industrial environments. FVG's 30-year engineering heritage in Asia and North America is the foundation for this positioning, and the current investment in engineering talent and process capability is what keeps it current.

Malaysia's strategic position in supply chain diversification

FVG's Johor operations sit at an inflection point in global supply chain strategy. The migration of 30–40% of China-destined EMS production to friendlier-shore locations is creating a structural increase in demand for qualified Malaysian manufacturers. Malaysia's role as a global electronics manufacturing hub is being reinforced by government investment, infrastructure development, and the presence of six of the world's twelve largest semiconductor companies in the country.

For FVG, this is not a passive tailwind. The company is actively investing in the capabilities required to serve multinational OEMs that are restructuring their supply chains away from single-geography dependence. That means ISO-certified quality systems, documented traceability, dual-source supply strategies, and the engineering capacity to support rapid NPI for customers who need to qualify a new manufacturing partner quickly.

The investment logic in summary: FVG is allocating capital to segments where demand is growing structurally, where barriers to entry are high enough to protect margins, and where its existing capabilities provide a credible starting point. This is not speculative growth investment; it is targeted expansion into adjacent positions that the company's engineering and quality infrastructure already supports.

How the Two Tracks Connect: From Cost Discipline to Margin Recovery

The cost-reduction and growth-investment programmes are not parallel strategies. They are sequential steps in a single financial recovery plan. Understanding how they interact is important for assessing whether FVG's current trajectory is credible.

The table below maps the key initiatives to their expected financial contribution:

The near-term initiatives are designed to stabilise and improve the current cost base. The medium-to-long-term investments are designed to shift the revenue mix toward higher-margin segments. Both are necessary; neither is sufficient on its own.

The risk of the alternative

It is worth stating plainly what the alternative approach would look like. An EMS provider facing margin pressure could respond by deferring capital investment, cutting engineering headcount, and competing on price in commodity segments. This would improve short-term cash generation. It would also destroy the engineering capability and quality system maturity that differentiate FVG in medical and industrial markets, the segments where sustainable margins actually exist.

The companies that have taken this path in the EMS industry have generally found themselves trapped in a race to the bottom on price, competing with lower-cost Asian manufacturers on the one dimension where those manufacturers have the most structural advantage. That is not a recoverable position.

FVG's current programme accepts short-term financial pressure in exchange for a stronger competitive position in segments where engineering credibility, quality system maturity, and supply chain reliability are the primary selection criteria. That is a rational trade-off, provided the investment is executed with discipline and the cost initiatives deliver their expected savings on schedule.

What Stakeholders Should Be Watching

For clients, partners, and investors evaluating FVG's financial trajectory, the relevant indicators are not the headline revenue figures for any single quarter. They are the operational and commercial metrics that signal whether the underlying programme is working.

Operational indicators

• Gross margin trend by segment: Improvement in medical and industrial automation gross margins, even if total revenue is flat, indicates successful mix shift

• OEE across key production lines: Sustained improvement in OEE above 75% on SMT and box-build lines indicates lean programme effectiveness

• Energy cost as a percentage of revenue: Stabilisation or reduction despite tariff increases indicates solar infrastructure is delivering its intended offset

• First-pass yield rates: Maintenance or improvement of first-pass yield during volume ramp indicates quality systems are scaling correctly

Commercial indicators

• New customer wins in medical and industrial segments: Qualification of new OEM customers in these verticals is the leading indicator of future revenue mix improvement

• Programme lifetime value: Longer-term, higher-complexity programmes entering production indicate the engineering investment is attracting the right customer profile

• NPI-to-production conversion rate: The proportion of NPI engagements that convert to production programmes indicates commercial effectiveness of the engineering-led sales approach

The current period of mixed financial momentum will resolve in one of two directions: either the cost initiatives deliver their expected savings and the growth investments begin contributing to revenue, or they do not. The indicators above will show which direction the trajectory is moving before it appears in headline financial results.

For OEM customers considering FVG as a manufacturing partner, the practical question is simpler: is FVG investing in the capabilities that matter for your programmes, and is it doing so in a way that suggests operational stability rather than financial distress? The answer, based on the programme described above, is yes on both counts.

FVG's 30-year operating history across Asia and North America is the most relevant evidence of financial resilience. Companies that survive and grow through multiple industry cycles, including the post-COVID component crisis of 2021–2023 and the current tariff and energy cost environment, do so because they make structurally sound decisions under pressure. The current programme is consistent with that history.

For further information on FVG's engineering capabilities and manufacturing approach, see how FVG enables scalable production and FVG's contribution to Malaysia's electronics manufacturing growth.